Injecting one thing for testing and then adding adjuvant later............
"the CDC lady says the vaccine being used in the
clinical trials does NOT contain any adjuvant."
From: Susan
Kreider
"Kreider, Susan" <Susan.Kreider@uphs.upenn.edu> and posted with
permissions
(PS Susan is vaccine injured from hep b vaccine received as a nurse)
Dr. Harold Buttram and I attended this meeting in Trevose, PA on Saturday. The
CDC spokeswoman was ill-informed even about the party line.
A few gentlemen brought up the Baxter incident. The spokewoman had to check her
sources and later assured us that Baxter is not among the 5 sources providing
our flu vaccine.
One of the Keystone organizers made a slip about the CDC trying to “keep our
kids sick” and got booed by several of us. Freudian slip? I hope that was picked
up by one of the videographers.
The CDC spokeswoman botched the power-point slide on incidence of Guillian-Barre’
Syndrome. The slide (which was not reproduced among our handouts along with the
other copied slides, I note) indicated one case in 1-4 million people. She
‘corrected’ that figure later, saying that 1 in 100,000 people developed GBS
following the 1976 swine flu debacle. According to the International GBS
Foundation (Narberth, PA) literature, the ‘usual’ incidence of GBS is 1 in
100,000 and was twice that following the swine flu vax debacle.
Moreover, as I stated in my small group Saturday, in 1994 when I filed my VAERS
Report my neurologist misdiagnosed my GBS sensory-variant as “Peripheral Sensory
Neuronopathy of idiopathic origin.” The administering hospital documented no Lot
#s and my Consent Form said “Heptavax” rather than recombinant hepatitis B
vaccine. Voluntary post-surveillance VAERS is garbage for so many reasons not
lost to members our (VacLib) forum. The incidence of GBS –and its causesare
underreported.
The CDC official discussed viral “drifts” and “shifts” but failed to discuss
viral “shedding” through bodily fluids. One guy in the public audience wanted to
discuss “shedding.” I jumped on that bandwagon myself as related to kids
receiving flu vaccines via nasal sprays. Early on I had posed to the CDC
spokeswoman my complaint that while most kiddie vaccines were supposed to be
available with less mercury-containing thimerosal preservative by 2001 but then
almost immediately the CDC began recommending that expanding groups of children
receive 2 ½-doses of regular flu shots that still contain mercury. Since the
technology is available to reduce thimerosal, why are we still using thimerosal
in flu shots all these years later?
Squalene adjuvant was brought up by a few people in the audience.
Interestingly, Dr. Buttram found a Vaclib.org exemption form in his packet!
Sadly it was not in my folder or the folder of the gentleman seated to his
right. Overall, Dr. Buttram and I were pleasantly surprised by the number of
folks in the audience who question vaccination safety and efficacy; he counted 7
out of 8 at our table. Probably there were no more than 150 folks at this public
engagement hearing. The report won’t become available until after they’ve
started doling out the vaccines which they assure are voluntary (at least while
the flu has demonstrated to be fairly mild.) I don’t trust the accuracy of the
electronic polling that went on at the end of the day, either. The food was
horrible and my nutritionist Patricia Kane, PhD would be upset with what
(denatured) food choices were available; we weren’t allowed to leave.
and ..................
the CDC lady says the vaccine being used in the clinical trials does NOT
contain any adjuvant. Now you know that the adjuvant will soon be added because
the virus has been reproducing so poorly… Oh my nerves…
Susan
Philly, PA